Conduction System Pacing With INGEVITY+
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Friedman, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sarasota Memorial Health Care System
Sarasota, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Community Heart and Vascular Hospital
Indianapolis, Indiana, United States
- Essentia Health - Saint Mary'S Duluth Clinic
Duluth, Minnesota, United States
- Newyork-Presbyterian Queens
Flushing, New York, United States
- Duke University
Durham, North Carolina, United States
- Trihealth Bethesda North Hospital
Cincinnati, Ohio, United States
- Houston Methodist Sugar Land Hospital
Sugar Land, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Nov 2023
- Primary completion
- 27 Aug 2024
- Completion
- 27 Aug 2024
- Last update posted
- 23 May 2025
- Registered enrollment
- 1,383
- Registry id
- NCT06014866
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.